Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.7.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Feb. 28, 2017
Aug. 31, 2016
Current    
Cash $ 523,633 $ 93,409
Accounts and other receivable 23,630 131,083
Inventory 143,367 134,724
Prepaid expenses and deposit 113,062 150,950
Total Current Assets 803,692 510,166
Patents 63,261 53,997
Equipment 2,166 2,475
Total Noncurrent Assets 65,427 56,472
TOTAL ASSETS 869,119 566,638
Current    
Accounts payable and accrued liabilities 25,963 90,010
Unearned revenue 24,969 12,500
Due to related parties 282,615 331,371
Total Current Liabilities 333,547 433,881
Convertible debenture 45,000 45,000
TOTAL LIABILITIES 378,547 478,881
STOCKHOLDERS' EQUITY    
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 56,293,479 common shares at February 28, 2017 and 51,288,473 common shares at August 31, 2016 56,292 51,288
Additional paid-in capital 12,778,765 11,515,419
Deficit (12,143,889) (11,300,662)
Equity attributable to shareholders of the Company 691,168 266,045
Non-Controlling Interest (200,596) (178,288)
Total Stockholders' Equity 490,572 87,757
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 869,119 $ 566,638